Aerie Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AERI Nasdaq 2834 http://www.aeriepharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aerie Pharmaceuticals Inc

Aerie Pharmaceuticals Announces Appointment of Amine Sinmazisik as Director, Finance - Dec 9th, 2019 11:30 am
Aerie (AERI) Up 4.7% Since Last Earnings Report: Can It Continue? - Dec 6th, 2019 4:31 pm
Is Aerie Pharmaceuticals Inc (AERI) A Good Stock To Buy ? - Dec 4th, 2019 2:19 pm
Aerie Pharmaceuticals Submits Marketing Authorisation Application for Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in Europe - Dec 3rd, 2019 11:15 am
Did Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Insiders Buy Up More Shares? - Dec 2nd, 2019 9:56 am
5 “Strong Buy” Biotech Stocks With More Than 80% Upside - Nov 27th, 2019 2:45 pm
Aerie Pharmaceuticals to Present at the Piper Jaffray 31st Annual Healthcare Conference - Nov 26th, 2019 11:30 am
The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate - Nov 22nd, 2019 1:18 pm
Aerie Pharmaceuticals Receives European Commission Approval for Rhokiinsa® (netarsudil ophthalmic solution) 0.02% - Nov 21st, 2019 11:30 am
Aerie buys Spanish outfit as it moves toward profitability - Nov 19th, 2019 3:58 pm
Aerie to Acquire Dry Eye Disease-Focused Pharma Avizorex - Nov 19th, 2019 2:31 pm
Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma, S.L. to Advance Its Dry Eye Program - Nov 18th, 2019 11:30 am
Aerie Pharmaceuticals to Present at the Stifel 2019 Healthcare Conference - Nov 12th, 2019 12:30 pm
Edited Transcript of AERI earnings conference call or presentation 6-Nov-19 10:00pm GMT - Nov 12th, 2019 10:41 am
Aerie (AERI) Q3 Loss Wider, Sales Beat, Guidance Slashed - Nov 7th, 2019 3:51 pm
The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs - Nov 7th, 2019 12:18 pm
Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates - Nov 6th, 2019 11:05 pm
Aerie Pharmaceuticals Completes Enrollment in the Phase 2 Trial of AR-1105 (Dexamethasone Intravitreal Implant) in Patients with Macular Edema Associated with Retinal Vein Occlusion Ahead of Schedule - Oct 24th, 2019 10:30 am
Edited Transcript of AERI earnings conference call or presentation 7-Aug-19 9:00pm GMT - Oct 16th, 2019 11:15 pm